Evidence map›Paper›PMID 41599682›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Tilianin Attenuates Myocardial Ischemia-Reperfusion Injury by Targeting RIP3-Mediated Necroptosis.

Ruifang Zheng, Jie Yang, Xuemeng Wang, Yuanyuan Jin, Yue Wang, Wenling Su, Naihong Chen, Shifeng Chu, Jianguo Xing, Ming Xu

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A baseline systemic inflammatory signature predicts anti-PD-1 response in advanced melanoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Article
  3. N-International journal of molecular sciences · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ruifang ZhengSchool of Preclinical Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Jie YangXinjiang Key Laboratory of Uygur Medical Research, Xinjiang Institute of Materia Medica, Urumqi 830004, China.
Xuemeng WangXinjiang Key Laboratory of Uygur Medical Research, Xinjiang Institute of Materia Medica, Urumqi 830004, China.
Yuanyuan JinInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing 100050, China.
Yue WangXinjiang Key Laboratory of Uygur Medical Research, Xinjiang Institute of Materia Medica, Urumqi 830004, China.
Wenling SuXinjiang Key Laboratory of Uygur Medical Research, Xinjiang Institute of Materia Medica, Urumqi 830004, China.
Naihong ChenXinjiang Key Laboratory of Uygur Medical Research, Xinjiang Institute of Materia Medica, Urumqi 830004, China.
Shifeng ChuXinjiang Key Laboratory of Uygur Medical Research, Xinjiang Institute of Materia Medica, Urumqi 830004, China.
Jianguo XingXinjiang Key Laboratory of Uygur Medical Research, Xinjiang Institute of Materia Medica, Urumqi 830004, China.
Ming XuSchool of Preclinical Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China.

Funding

Leading Talents in Scientific and Technological Innovation of Tianshan Mountain 2023TSYCLJ0042National Natural Science Foundation of China 82260845National Natural Science Foundation of China 82460848Natural Science Foundation of Xinjiang Uygur Autonomous Region 2022D01D50Tianshan Talent Training Program: Youth Support Talent Program 2023TSYCQQTJ0010
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CaMKIImitochondrial membrane permeability transition poremyocardial ischemic reperfusion injurynecroptosisRIP3Tilianin

Identifiers

PMID41599682
PMCPMC12844720

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.